|
Volumn 14, Issue 22, 2003, Pages 3525-3531
|
Practical synthesis of (R)-(+)-6-(1,4-dimethoxy-3-methyl-2-naphthyl)-6-(4- hydroxyphenyl)hexanoic acid: A key intermediate for a therapeutic drug for neurodegenerative diseases
|
Author keywords
[No Author keywords available]
|
Indexed keywords
(1,4 DIMETHOXY 3 METHYL 2 NAPTHYL) 6 (4 HYDROXYLPHENYL)HEXANOIC ACID;
1,4 NAPHTHOQUINONE DERIVATIVE;
CHLORINE DERIVATIVE;
ESTER;
HEXANOIC ACID DERIVATIVE;
METHYL 6 (1,4 DIMETHOXY 3 METHYL 2 NAPHTHYL) 6 [4 (PROPIONYLOXY)PHENYL]HEXANOATE;
NEUROPROTECTIVE AGENT;
PYRIDINE DERIVATIVE;
UNCLASSIFIED DRUG;
ARTICLE;
CATALYSIS;
CRYSTALLIZATION;
DEGENERATIVE DISEASE;
DRUG SYNTHESIS;
ENANTIOMER;
EXTRACTION;
HYDROLYSIS;
OPTICAL RESOLUTION;
PHOSPHORYLATION;
PRIORITY JOURNAL;
PURIFICATION;
SULFATION;
|
EID: 0242626766
PISSN: 09574166
EISSN: None
Source Type: Journal
DOI: 10.1016/S0957-4166(03)00580-9 Document Type: Article |
Times cited : (18)
|
References (15)
|